Trial Profile

Phase 3 pivotal clinical trial evaluating VYD2311 safety and prevention of COVID versus placebo

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 13 Nov 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs VYD 2311 (Primary)
Indications COVID 2019 infections
Focus Registrational; Therapeutic Use
Acronyms DECLARATION

Most Recent Events

13 Nov 2025 New trial record
06 Oct 2025 According to Invivyd media release, DECLARATION and LIBERTY clinical trials to be funded by Invivyds recent capital raise
06 Oct 2025 According to Invivyd media release, the DECLARATION clinical trial is the companys Biologics License Application (BLA) enabling, Phase 3 pivotal clinical trial

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com